Valuation: Vitrolife AB

Market Cap 13.24B 1.34B 1.19B 1.1B 1B 1.88B 127B 1.91B 5.2B 66.62B 5.04B 4.93B 214B P/E 2026 *
26.5x
P/E 2027 * 20.8x
Enterprise Value 13.94B 1.41B 1.26B 1.16B 1.05B 1.98B 133B 2.01B 5.47B 70.11B 5.3B 5.19B 225B EV / Sales 2026 *
4.01x
EV / Sales 2027 * 3.55x
Free-Float
54.39%
Yield 2026 *
1.14%
Yield 2027 * 1.36%
1 day+0.05%
1 week-0.81%
Current month+2.84%
1 month+6.89%
3 months+8.79%
6 months-11.89%
Current year-28.61%
1 week 95.55
Extreme 95.55
99.65
1 month 89.6
Extreme 89.6
100.5
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/26 A Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 A Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 A Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-0.81%-30.83%-29.03% 1.34B
-1.89%-2.05%-22.39%+3.85% 177B
-2.23%+5.33%-21.93%+12.01% 117B
-1.69%+0.02%-3.01%+27.96% 116B
+15.48%+18.80%-44.63%+6.59% 77.71B
-0.83%+3.13%+3.98%+80.36% 65.51B
+1.98%+4.70%+17.36%+81.35% 54.97B
+0.28%+3.72%+1.75%-24.86% 52.79B
-0.80%+6.38%-13.98%+29.62% 43.95B
-6.39%-5.64%+17.29%-6.64% 32.35B
Average +0.57%+2.94%-9.64%+18.12% 73.85B
Weighted average by Cap. +0.75%+3.02%-12.37%+20.73%

Financials

2026 *2027 *
Net sales 3.48B 353M 313M 290M 263M 495M 33.3B 501M 1.36B 17.5B 1.32B 1.29B 56.09B 3.78B 383M 341M 315M 286M 538M 36.19B 544M 1.48B 19.01B 1.44B 1.41B 60.95B
Net income 498M 50.54M 44.91M 41.58M 37.66M 70.88M 4.77B 71.78M 196M 2.51B 190M 186M 8.04B 631M 64M 56.87M 52.65M 47.69M 89.76M 6.04B 90.89M 248M 3.18B 240M 235M 10.18B
Net Debt 694M 70.41M 62.57M 57.93M 52.47M 98.76M 6.65B 100M 272M 3.49B 264M 258M 11.2B 160M 16.17M 14.37M 13.3M 12.05M 22.68M 1.53B 22.97M 62.57M 802M 60.64M 59.36M 2.57B
Projected Income Statement - Annual - Vitrolife AB
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
21/10/26 SEK 97.80 +0.05% 65,340
20/10/26 SEK 97.75 -0.05% 96,601
19/10/26 SEK 97.80 -0.36% 77,477
16/10/26 SEK 98.15 -0.71% 79,262
15/10/26 SEK 98.85 +0.87% 229,824
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Vitrolife AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
97.80SEK
Average target price
131.20SEK
Spread / Average Target
+34.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Vitrolife AB
  1. Stock Market
  2. Stocks
  3. VITR Stock